- Category
- Micro (2024-25)
- Udyam number
- UDYAM-MH-15-0115656

About Ripcord Pharmaceuticals Private Limited
Data last updated:
Ripcord Pharmaceuticals Private Limited is a private limited company based in Kolhapur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 21 November 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U74999PN2017PTC173517. Its GSTIN is 27AAICR6311A1ZR (Maharashtra).
The company has an authorised share capital of ₹1 Cr and a paid-up capital of ₹50 Lakh. It is led by directors including Bhavin Nimesh Madhu (Managing Director) and Indu Nimesh Madhu.
Its last annual general meeting (AGM) was held on 30 September 2023, and its latest financial statements are for the year ended 31 March 2023. The registered office is at F 105 Paraag Complex 596 E Ward 1st Lane Shahupuri, Kolhapur, Maharashtra, India – 416001.
As per the financials filed for FY 2023, the company reported a revenue of ₹21.39 Lakh. For the same year it recorded a net profit of ₹88,138 (net margin 4.1%) and EBITDA of ₹10.32 Lakh (EBITDA margin 48.2%).
As per MCA filings, the company has open charges of ₹1.88 Cr on record.
Ripcord Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-15-0115656). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ripcordpharma.com.
Company details
Recognitions & Rankings of Ripcord Pharmaceuticals
Contact details
Ripcord Pharmaceuticals Private Limited's registered office is in Kolhapur, Maharashtra. Its website is ripcordpharma.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressF 105 Paraag Complex 596 E Ward 1st Lane Shahupuri, Kolhapur, Maharashtra, India – 416001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ripcord Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ripcord Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Ripcord Pharmaceuticals Private Limited, buy the company report.
Financials of Ripcord Pharmaceuticals Private Limited
FY 2023 filings availableRipcord Pharmaceuticals Private Limited reported revenue of ₹21.39 Lakh for FY 2023.
Financial Statement Summary
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹10.32 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹88,138 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 48.2% | ||||
| Net Profit Margin | 4.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ripcord Pharmaceuticals Private Limited, buy the company report.
Board of directors of Ripcord Pharmaceuticals Private Limited
Ripcord Pharmaceuticals has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Indu Nimesh Madhu | Director | 21 Nov 2017 | 8 Years 11 Months | Current |
| Mihir Nimesh Madhu | Director | 21 Nov 2017 | 8 Years 11 Months | Current |
| Komal Nimesh Madhu | Director | 21 Nov 2017 | 8 Years 11 Months | Current |
| Bhavin Nimesh Madhu | Managing Director | 21 Nov 2017 | 8 Years 11 Months | Current |
Auditor
Ripcord Pharmaceuticals Private Limited is audited by A K UMRANI & CO for the financial year 2022.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| A K UMRANI & CO | FY 2022 | 114138W |
Shareholding
The shareholding of Ripcord Pharmaceuticals Private Limited is on record for 5 financial years, the latest being FY 2022, split between promoters, domestic institutions, public shareholders and others.
| Shareholder category | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Ripcord Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 09 Mar 2019 | 100264706 | Others | ₹1.88 Cr | Open |
To see the full charge records of Ripcord Pharmaceuticals Private Limited, buy the company report.
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Ripcord Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ripcord Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Ripcord Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAICR6311A1ZR | Maharashtra | Active | 04 Jun 2018 |
To see the full GST registrations and return filing status of Ripcord Pharmaceuticals Private Limited, buy the company report.
Recent activity
Ripcord Pharmaceuticals Private Limited has 5 board changes on record since 2017: 4 appointments and 1 cessation. The latest: Anand Devichand Shah ceased to be Director on 07 May 2018.
Frequently asked questions
Ripcord Pharmaceuticals is an active private limited company based in Kolhapur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 21 November 2017 (9+ years old) and is registered under CIN U74999PN2017PTC173517.
Ripcord Pharmaceuticals has 4 current directors:
- Bhavin Nimesh Madhu - Managing Director
- Indu Nimesh Madhu - Director
- Mihir Nimesh Madhu - Director
- Komal Nimesh Madhu - Director
The latest financial statements of Ripcord Pharmaceuticals on record with the MCA are for the year ended 31 March 2023. Its last annual general meeting was held on 30 September 2023. Year-wise statements from FY 2018 are in the company report.
The GSTIN of Ripcord Pharmaceuticals is 27AAICR6311A1ZR, registered in Maharashtra.
The CIN (Corporate Identification Number) of Ripcord Pharmaceuticals is U74999PN2017PTC173517. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ripcord Pharmaceuticals was incorporated on 21 November 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
Anand Devichand Shah ceased to be Director on 07 May 2018. Bhavin Nimesh Madhu was appointed as Managing Director on 21 Nov 2017. Indu Nimesh Madhu was appointed as Director on 21 Nov 2017. Ripcord Pharmaceuticals has 5 board changes on record in total.
Yes, Ripcord Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-15-0115656).
Ripcord Pharmaceuticals can be reached through the website ripcordpharma.com. Its registered office is in Kolhapur, Maharashtra, India.
The registered office of Ripcord Pharmaceuticals is at F 105 Paraag Complex 596 E Ward 1st Lane Shahupuri, Kolhapur, Maharashtra, India – 416001.

